Apo-Abiraterone Film Coated Tablets

Active ingredients

• Abiraterone Acetate — 500 mg

Form and route

Tablet · Oral

Schedule

PRESCRIPTION

Authorised since

2021-01-25

Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.

• Zytiga02457113Janssen IncAbiraterone Acetate 500 mgTablet
• PMS-Abiraterone02501503Pharmascience IncAbiraterone Acetate 500 mgTablet
• Mar-Abiraterone02503999Marcan Pharmaceuticals IncAbiraterone Acetate 500 mgTablet
• Sandoz Abiraterone02521644Sandoz Canada IncorporatedAbiraterone Acetate 500 mgTablet
• Jamp Abiraterone02529629Jamp Pharma CorporationAbiraterone Acetate 500 mgTablet
• Reddy-Abiraterone02533251DR Reddy's Laboratories LtdAbiraterone Acetate 500 mgTablet
• PRZ-Abiraterone02540460Pharmaris Canada IncAbiraterone Acetate 500 mgTablet

Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.

Anatomical main group

Antineoplastic and immunomodulating agents

ATC code

L02BX03

The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of L02BX03, see the WHO ATC/DDD Index.